Literature DB >> 18724308

Why are there regional differences in stem cell transplantation activity? An EBMT analysis.

A Gratwohl1, H Baldomero, K Frauendorfer, D Niederwieser.   

Abstract

Differences in the number of hematopoietic SCTs (HSCT), in transplant rates, in indications and in techniques between countries have been reported. They were attributed mainly to differences in the economic situation of the countries or to differences in prevalences of the disease. On the basis of the results of the annual activity survey on HSCT of the European Blood and Marrow Transplantation (EBMT), we have analyzed the factors associated with differences between more than 600 teams participating from more than 40 countries over a time span of 15 years. The results show a more complex situation. The gross national income per capita, number of transplant teams per 10 million inhabitants or per 10,000 km2, team size and team experience all impact on transplant activity. Furthermore, hitherto unknown factors must add to the decisions to perform or not to perform HSCT. These data illustrate that more research is needed to understand the mechanism of HSCT activity and to enable health-care agencies to provide the necessary infrastructure.

Mesh:

Year:  2008        PMID: 18724308     DOI: 10.1038/bmt.2008.104

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  9 in total

1.  Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report.

Authors:  M D Aljurf; S Z Zaidi; H El Solh; F Hussain; A Ghavamzadeh; H K Mahmoud; T Shamsi; T Ben Othman; M M Sarhan; D Dennison; A Ibrahim; S Benchekroun; N Chaudhri; B Labar; M Horowitz; D Niederwieser; A Gratwohl
Journal:  Bone Marrow Transplant       Date:  2008-12-01       Impact factor: 5.483

2.  Differences in stem cell transplantation activity among regions in Spain: an economic explanation.

Authors:  I Espigado; M Ortega-Ortega; R Montero-Granados; N Rodriguez-Torres; F J Márquez-Malaver
Journal:  Bone Marrow Transplant       Date:  2016-07-04       Impact factor: 5.483

3.  Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007.

Authors:  Syed O A Ahmed; Ardeshir Ghavamzadeh; Syed Z Zaidi; Helen Baldomero; Marcelo C Pasquini; Fazal Hussain; Kamran Alimoghaddam; Fahad Almohareb; Mouhab Ayas; Amir Hamidieh; Hossam K Mahmoud; Alaa Elhaddad; Tarek Ben Othman; Abdelrahman Abdelkefi; Mahmoud Sarhan; Fawzi Abdel-Rahman; Salman Adil; Salam Alkindi; Ali Bazarbachi; Said Benchekroun; Dietger Niederwieser; Mary Horowitz; Alois Gratwohl; Hassan El Solh; Mahmoud Aljurf
Journal:  Biol Blood Marrow Transplant       Date:  2011-04-01       Impact factor: 5.742

4.  Chronic Myeloid Leukaemia: A paradigm for malignancy or just a strange disease?

Authors:  Shaun R McCann
Journal:  Sultan Qaboos Univ Med J       Date:  2012-11-20

5.  Quality control and assurance in hematopoietic stem cell transplantation data registries in Japan and other countries.

Authors:  Yachiyo Kuwatsuka
Journal:  Int J Hematol       Date:  2015-11-13       Impact factor: 2.490

6.  The perceived threat in adults with leukemia undergoing hematopoietic stem cell transplantation.

Authors:  Zahra Farsi; Nahid Dehghan Nayeri; Reza Negarandeh
Journal:  Nurs Midwifery Stud       Date:  2013-06-27

Review 7.  Hematopoietic Stem Cell Transplantation: A Bioethical Lens.

Authors:  Arcangelo Liso; Margherita Neri; Francesca Maglietta; Raffaele La Russa; Emanuela Turillazzi
Journal:  Stem Cells Int       Date:  2017-06-27       Impact factor: 5.443

8.  Is belief larger than fact: expectations, optimism and reality for translational stem cell research.

Authors:  Tania Bubela; Matthew D Li; Mohamed Hafez; Mark Bieber; Harold Atkins
Journal:  BMC Med       Date:  2012-11-06       Impact factor: 8.775

9.  Regional differences in performance of bone marrow transplantation, care-resource use and outcome for adult T-cell leukaemia in Japan.

Authors:  Toshiki Maeda; Akira Babazono; Takumi Nishi; Shinya Matsuda; Kiyohide Fushimi; Kenji Fujimori
Journal:  BMC Health Serv Res       Date:  2014-08-08       Impact factor: 2.655

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.